CME Group Inc. Stock
CME Group Inc. Stock
We can see a decrease in the price for CME Group Inc.. Compared to yesterday it has lost -€2.850 (-1.230%).
Currently there is a rather positive sentiment for CME Group Inc. with 34 Buy predictions and 16 Sell predictions.
As a result the target price of 262 € shows a slightly positive potential of 14.41% compared to the current price of 229.0 € for CME Group Inc..
For the coming years our community has positive and negative things to say abot the CME Group Inc. stock. Criterium "EBIT growth" gathered the most positive votes but regarding "Expected dividend yield" there were negative voices in the community.
Pros and Cons of CME Group Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CME Group Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CME Group Inc. | -1.230% | 6.134% | 21.210% | -2.502% | -1.987% | 28.165% | 29.294% |
| Fidelity National Information Services Inc. | 3.290% | 15.138% | 20.851% | -42.138% | -28.236% | -24.362% | -67.459% |
| Intercontinental Exchange Inc. | 0.700% | 8.006% | 25.372% | -15.677% | -3.560% | 28.967% | 32.710% |
| MarketAxess Holdings | 28.720% | 10.960% | 14.189% | -38.751% | -29.673% | -55.218% | -72.190% |
sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-18
Upon first examination of the financial statements for CME Group (ticker: CME), a company from the Investment Banking and Investment Services industry, it appears that the company maintains a solid financial foundation. It is evident that the company has experienced substantial growth over the years, expanding in key financial areas such as assets, revenues, and net income.
*Pros: *
Growth in total assets: CME Group has consistently grown its total assets from 124.6 billion USD in 2020 to 174.1 billion USD in 2022. The growth is driven by both current and non-current assets. The increase in current assets can signal an enhanced liquidity position for the company.
Comments
CME Group (CME) had its price target raised by JPMorgan Chase & Co. from $249.00 to $250.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for CME provided by MarketBeat
CME Group (CME) had its price target raised by Bank of America Corporation from $226.00 to $230.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for CME provided by MarketBeat
CME Group (CME) had its "overweight" rating reaffirmed by Morgan Stanley.
Show more
Ratings data for CME provided by MarketBeat